| Literature DB >> 35128307 |
Abstract
The Wnt family is a large class of highly conserved cysteine-rich secretory glycoproteins that play a vital role in various cellular and physiological courses through different signaling pathways during embryogenesis and tissue homeostasis 3. Wnt5a is a secreted glycoprotein that belongs to the noncanonical Wnt family and is involved in a wide range of developmental and tissue homeostasis. A growing body of evidence suggests that Wnt5a affects embryonic development, signaling through various receptors, starting with the activation of β-catenin by Wnt5a. In addition to affecting planar cell polarity and Ca2+ pathways, β-catenin also includes multiple signaling cascades that regulate various cell functions. Secondly, Wnt5a can bind to Ror receptors to mediate noncanonical Wnt signaling and a significant ligand for Ror2 in vertebrates. Consistent with the multiple functions of Wnt5A/Ror2 signaling, Wnt5A knockout mice exhibited various phenotypic defects, including an inability to extend the anterior and posterior axes of the embryo. Numerous essential roles of Wnt5a/Ror2 in development have been demonstrated. Therefore, Ror signaling pathway become a necessary target for diagnosing and treating human diseases. The Wnt5a- Ror2 signaling pathway as a critical factor has attracted extensive attention.Entities:
Keywords: Ror2; Wnt5a; tetralogy of Fallot; β-catenin-mediated and β-catenin-independent
Year: 2022 PMID: 35128307 PMCID: PMC8808015 DOI: 10.1177/25168657211064232
Source DB: PubMed Journal: Epigenet Insights ISSN: 2516-8657
Wnt protein associated function, gene location, and related diseases.
| Aliases | Gene location (human) | Function | Associated disease |
|---|---|---|---|
| Proto-oncogene Wnt-1 | 12q13.12 | Involve with oncogenesis, cells differentiation in the embryogenesis, formation of the embryonic dorsal neural tube, and initiation of mesencephalon and cerebellum | Joubert syndrome, autism, osteogenesis imperfecta, and type XV
|
| WNT2 | 7q31.2 | Involve with oncogenesis, cell differentiation in the embryogenesis, cognitive/linguistic, and midbrain dopaminergic neuron development. | Autism[ |
| Wnt-2b (formerly Wnt-13) | 1p13.2 | Controlling mesoderm specification and some aspects of brain, heart, and lung during gastrulation. | Diarrhea 9 (DIAR9)
|
| Wnt3 | 17q21.31-q21.32 | Involve with oncogenesis, cell differentiation in the embryogenesis | Tetraamelia syndrome and tetra-amelia syndrome
|
| Wnt3a | 1q42.13 | Involve with oncogenesis, adipogenesis, and cell differentiation in the embryogenesis | Osteoporosis, juvenile, and hypotrichosis
|
| Wnt4 | 1p36.12 | Aggravate the testis-determining factor, regulates endometrial stromal cell proliferation, survival, and differentiation | SERKAL syndrome, Mullerian aplasia, and hyperandrogenism[ |
| Wnt5a | 3p14.3 | Cell differentiation in the embryogenesis, posterior development of the female reproductive tract, and cardiac outflow tract | Robinow syndrome, autosomal dominant, congenital heart disease[ |
| Wnt5b | 12p13.33 | Cell differentiation in the embryogenesis, regulation of cardiac development | Type 2 diabetes, fallopian tube serous adenocarcinoma, and colorectal cancer
|
| Wnt6 | 2q35 | Key roles in cell differentiation during embryogenesis, carcinogenesis, and inhibits the induction of cardiogenic mesoderm | Mullerian aplasia and hyperandrogenism, and gastric cancer
|
| Wnt7a | 3p25.1 | Roles in cell differentiation during embryogenesis, the development of the anterior-posterior axis in the female reproductive tract, and uterine smooth muscle | Fuhrmann syndrome, Schinzel phocomelia syndromes, fibular aplasia, or hypoplasia
|
| Wnt7b | 22q13.31 | Regulating of cell fate and patterning during embryogenesis, placental, lung, eye, dendrite, and bone formation along with kidney development | Beckwith-Wiedemann syndrome, microphthalmia, syndromic 9 and colobomatous microphthalmia
|
| Wnt8a | 5q31.2 | Development of early embryos and germ cell tumors | Exudative vitreoretinopathy 1 and Norrie disease. |
| Wnt8b | 10q24.31 | Roles in cell differentiation during embryogenesis | Exudative vitreoretinopathy 1, epilepsy, and Alzheimer’s disease. |
| Wnt9a (formerly Wnt14) | 1q42.13 | Involves oncogenesis and the regulation of cell differentiation during embryogenesis | Gastric cancer and exudative vitreoretinopathy 1. |
| Wnt9b (formerly Wnt15) | 17q21.32 | Required for craniofacial development, the standard fusion of the palate, embryonic kidney, and urogenital tract development | Cleft lip and Mayer-Rokitansky-Kuster-Hauser syndrome. |
| Wnt10a | 2q35 | Involves oncogenesis and the regulation of cell differentiation during embryogenesis | Odontoonychodermal dysplasia, Schopf-Schulz-Passage syndrome, Tooth agenesis, selective, promyelocytic leukemia, and Burkitt’s lymphoma. |
| Wnt10b (formerly Wnt12) | 12q13.12 | Involved in oncogenesis and the regulation of cell differentiation during embryogenesis, breast cancer, and governs adipogenesis | Breast cancer, split-hand/foot malformation, tooth agenesis |
| Wnt11 | 11q13.5 | Development of skeleton, kidney, and regulates cardiac chamber | Fallopian tube serous adenocarcinoma and exudative vitreoretinopathy[ |
| Wnt16 | 7q31.31 | Embryonic regulation of cell growth and differentiation | Basal cell carcinoma and nodular basal cell carcinoma.
|
Figure 1.Signaling pathways involved in CHD. In normal conditions, the Wnt/β-catenin pathway is kept inactive as the β-catenin is complex with APC/Axin complex. When the Wnt or other specific ligands bind with membrane receptors, including frizzled and Ror, or by situations in which APC/Axin become unstable, cascades become activated and increase the free form of β-catenin and is not being phosphorylated, leading to accumulation in the cytoplasm. Eventually, this free β-catenin is associated with nuclease and promotes the expression of several Wnt target genes. APC helps Axin phosphorylate β-catenin and subsequent degradation of β-catenin through ubiquitination if the cell remains inactive. Wnt/β-catenin non-canonical signaling pathway is transduced independent from β-catenin activation. After ligation, Dvl utilizing Daam 1 activates Rho kinase (RhoA). Dvl also activates CaMK, calcineurin, and PKC, resulting in subsequent activation of JNK. The integrity of these pathways leading to cytoskeletal changes and stimulation of cell polarization and mutilations during gastrulation.